The chemical class of Reg IIIα inhibitors is composed of agents that are designed to specifically target and hinder the biological function of Regenerating islet-derived protein III alpha (Reg IIIα). Reg IIIα is a member of the Regenerating (Reg) protein family, which is characterized by its involvement in cellular regeneration and homeostatic processes. Reg IIIα, like other Reg proteins, is a type of C-type lectin that is primarily expressed in the gastrointestinal tract and is implicated in cellular growth and differentiation. The modulation of Reg IIIα activity by these inhibitors occurs through the interruption of its interaction with specific carbohydrate structures on the surfaces of cells. This interaction is typically mediated by the carbohydrate recognition domain of the lectin, which is essential for the protein's biological function. Inhibitors of Reg IIIα can act by occupying this domain, preventing the protein's normal interaction with its ligands, or by altering the protein's conformation to reduce its functional capacity.
In the quest to identify effective Reg IIIα inhibitors, an extensive search through diverse chemical libraries is undertaken, leveraging advanced screening methodologies to pinpoint compounds that can bind to the lectin with high specificity and affinity. Such screens utilize an array of in vitro assays, including but not limited to carbohydrate-binding assays, to assess the potential of various molecules to block the interaction between Reg IIIα and its natural ligands. Following the initial identification of promising candidates, further assays are performed to ascertain the specificity of these inhibitors, ensuring they do not inadvertently affect the activity of other lectins or unrelated proteins. Techniques such as competitive inhibition assays, where potential inhibitors compete with natural ligands for binding to Reg IIIα, and biophysical methods including isothermal titration calorimetry (ITC) or surface plasmon resonance (SPR), are commonly employed to characterize the binding interactions in detail.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, Trichostatin A could affect chromatin structure and potentially decrease REG1A gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methylation, possibly leading to altered gene expression patterns including REG1A. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat inhibits histone deacetylases, which may change the chromatin state and affect REG1A transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor that could potentially reduce methylation levels and affect REG1A expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to DNA, Mithramycin A may inhibit transcription factor binding, potentially reducing REG1A expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits RNA polymerase action, which could decrease transcription of REG1A. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is a DNA methylation inhibitor that might lead to changes in REG1A expression by altering epigenetic marks. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat is an HDAC inhibitor that could potentially affect gene expression profiles, including that of REG1A. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus inhibits mTOR signaling, which can be involved in the regulation of various genes, potentially including REG1A. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects multiple cellular pathways and may lead to the downregulation of REG1A expression through these effects. | ||||||